Cell Encapsulation Membrane with Porous Polymer Coating for Immune Shielding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Cell implantation treatments face challenges such as immune system rejection and difficulty in ensuring sufficient oxygen and nutrient supply to transplanted cells due to biofouling and porous device designs.
Innovation Solution
A cell encapsulation membrane with a mesh substrate and a polymeric coating that controls porosity, including specific pore sizes and shapes, is used to shield cells from the immune system while allowing nutrient transport and resisting biofouling, featuring a hydrogel layer for enhanced vascularization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If cells are physically separated from the host environment within a porous pouch or container, then immune system rejection is reduced, but oxygen and nutrient transport to transplanted cells is insufficient
Solution Approach 1:
The patent employs a porous polymer coating with controlled porosity (pore size 0.5-5 microns) applied to a mesh substrate. This porous structure allows oxygen and nutrients to diffuse through the coating to reach encapsulated cells while maintaining physical separation from the host immune system. The pore size is specifically optimized to permit molecular transport while preventing cellular infiltration.
Solution Approach 2:
The invention uses a composite structure consisting of a mesh substrate (providing mechanical strength and structural support) combined with a porous polymer coating layer (providing selective permeability and biological compatibility). This composite material system simultaneously achieves immune protection and adequate nutrient transport by combining the advantages of both materials.
2Object-affected harmful factors
If a porous pouch or container is used to protect transplanted cells, then immune system attack is reduced, but biofouling occurs on device surfaces reducing nutrient reach
Solution Approach 1:
The patent modifies the surface properties of the polymer coating by controlling its porosity, pore size, and chemical composition to create a surface that resists biofouling. The specific pore size range (0.5-5 microns) and the use of biocompatible polymers change the surface parameters to prevent protein adsorption and bacterial adhesion, thereby reducing biofouling while maintaining immune protection.
3Quantity of substance
If a coating is applied to the mesh substrate to control porosity, then nutrient transport is improved, but the coating thickness must be precisely controlled to maintain effectiveness
Solution Approach 1:
The patent specifies a coating thickness range of 1-10 microns to optimize the balance between nutrient transport and immune protection. This parameter control ensures that the coating is thin enough to allow adequate diffusion of nutrients and oxygen while being thick enough to provide effective barrier function against immune cells. The mesh substrate structure beneath the coating provides dimensional stability that facilitates consistent coating application within this tight thickness range.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The membrane effectively shields cells from the immune system, facilitates high nutrient and gas transport, and resists biofouling, ensuring the viability of transplanted cells by controlling porosity and promoting vascularization.
Implementation Method 1
The coating partially occluding the plurality of apertures defined by the mesh substrate and forming pores
Implementation Method 2
it can be challenging to ensure that enough oxygen and nutrients will reach the transplanted cells to sustain them
Data Source
AI summary
Embodiments herein relate to cell encapsulation membranes, devices including the same, and related methods. In an embodiment, a cell encapsulation membrane is included. The cell encapsulation membrane can include a mesh substrate. The mesh substrate can include a first series of fibers extending in a first direction and a second series of fibers extending in a second direction, the first series of fibers intersecting with the second series of fibers, the mesh substrate defining a plurality of apertures disposed between adjacent fibers of the first series and the second series. The cell encapsulation membrane can further include a coating disposed on the mesh substrate, the coating partially occluding the plurality of apertures defined by the mesh substrate and forming pores. Other embodiments are also included herein.